EGYPT – Astute Imaging, a healthcare IT solutions company, has acquired Egyptian deep technology healthcare startup DilenyTech at an undisclosed amount.
DilenyTech was founded in 2018 to improve the accuracy of breast cancer screening and diagnostic workflow through innovative AI-based assistance for more precise detection and expedited reporting.
The Cairo-based startup develops solutions for medical imaging analysis, breast cancer risk assessment and structured reporting in several medical applications to top-tier international health-tech companies.
Earlier, DilenyTech was awarded a patent for an AI-enabled image analysis tool in 2020 and has since secured US$160,000 in grant funding last year to further AI-powered healthcare solutions.
The strategic acquisition of DilenyTech will enable Astute Imaging to leverage the power of AI to improve its current offering, expand services and develop innovative solutions in the medical imaging domain.
It will also enable Astute Imaging to accelerate the development of a technologically advanced therapy platform as well as amplify automation to the firm’s imaging services and procedure planning solutions,”.
“Empowering our surgery planning and patient follow-up imaging platforms with AI will help our customers and medical imaging stakeholders to provide more patient centric proactive services,” noted Wael Elseaidy, Co-founder of Astute Imaging.
DilenyTech Founder and Innovation Director Ahmed Ehab Mahmoud will be joining Astute Imaging’s founding team and managing the imaging operations to ensure smooth adoption of expertise and technologies to build reliable AI technologies for imaging-guided therapy.
“We have applied our technologies successfully in the area of breast imaging and we look forward to expanding our AI pipeline to other imaging areas such as thyroid, liver and gynecology as well as cardiovascular 3D imaging and procedural planning,” commented Ahmed.
He further acknowledged that Astute Imaging would be a gamechanger for healthcare providers and device companies.
The acquisition will empower Astute Imaging surgery planning and patient follow-up imaging platforms with AI which will help clients and medical imaging stakeholders to provide more patient centric proactive services.
The US firm also plans to develop predictive models for cardiovascular case-planning while expanding into other areas such as women’s health and cancer treatments.
These models will offer better insights to companies about the enhancement of interventional devices for image guided procedure, particularly in the cardiovascular and cancer domains.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
